ข่าวประชาสัมพันธ์ Boston Scientific+the Institute

Boston Scientific to Add New European Institute for Therapy Advancement Campus to Global Medical Education Network

Boston Scientific Corporation (NYSE: BSX) today announced plans for the construction of a new state-of-the art medical training facility in Brussels, Belgium designed to help health care professionals advance the standard of patient care. The Company expects the new addition to be completed in early 2007. "From our work at the Institute for Therapy Advancement over the past five years, we have learned which type of training is important to health care professionals," said Professor Jean Marco of

18 พฤษภาคม 2549 08:28 น.

เมดพาร์ค จัดสัมมนาวิชาการ Cardiac Arrhythmia Conference : Advances in Diagnosis and Management of Cardiac Arrhythmias — เมื่อวันศุกร์ที่ 28 มีนาคม 2568 โร... 02 เม.ย.

Bumrungrad Hospital Urology Center has been certified to perform minimally invasive treatment for enlarged prostates by Boston Scientific (USA). — Anyone can ... ก.ค. 65

Boston Scientific ได้รับการรับรอง CE Mark สำหรับกล้องส่องตรวจหลอดลมแบบใช้ครั้งเดียว EXALT(TM) Model B

บริษัทเตรียมวางจำหน่ายในบางตลาดของยุโรป เริ่มมิถุนายนนี้ Boston Scientific Corporation (NYSE: BSX) ประกาศได้รับการรับรอง CE Mark สำหรับกล้องส่องตรวจหลอดลมแบบใช้ครั้งเดียว EXALT(TM) Model B ซึ่ง... พ.ค. 64

Boston Scientific Completes CE Mark for EXALT(TM) Model B Single-Use Bronchoscope

Company to begin limited market release in Europe in June Boston Scientific Corporation (NYSE: BSX) today announced it has completed CE Mark for the EXALT(TM) Model B Single-Use Bronchoscope, a single-use device... พ.ค. 64

Symetis and Boston Scientific Reach USD 435 Million Purchase Agreement

- Definitive purchase agreement whereby Boston Scientific will acquire Symetis for $435 million in an all cash, up-front payment Acquisition of Symetis will expand the treatment offerings for patients with aortic valvular heart... มี.ค. 60

Joining Forces to Tackle Global Stroke Risk

The AF Association announces a collaboration with Boston Scientific Corporation, a global leader in innovative medical technology, to improve awareness of the most common heart rhythm disorder in the world, atrial fibrillation (AF). More than 71 million... ก.ย. 56

The World Stroke Organization and Boston Scientific Join Forces to Bolster Awareness and Advocacy Efforts

The World Stroke Organization will team with global medical technology leader Boston Scientific Corporation (NYSE:BSX), to further raise awareness and take action in the worldwide fight against... พ.ค. 56

บอสตัน ไซแอนทิฟิค จัดตั้งองค์กรใหม่ประจำภูมิภาคเอเชียแปซิฟิก

บอสตัน ไซแอนทิฟิค คอร์ปอเรชั่น (Boston Scientific Corporation) (NYSE: BSX) ประกาศจัดตั้งองค์กรใหม่ประจำภูมิภาคเอเชียแปซิฟิก ซึ่งประกอบไปด้วยออสเตรเลีย นิวซีแลนด์ จีน ฮ่องกง อินเดีย ญี่ปุ่น เกาหลีใต้ เอเชียตะวันออกเฉียงใต้ ไต้หวัน และตุรกี... ม.ค. 55

Boston Scientific Announces New Asia-Pacific Organization

Boston Scientific Corporation (NYSE: BSX) announces the creation of its Asia-Pacific regional organization that includes Australia, New Zealand, China, Hong Kong, India, Japan, South Korea, South East Asia, Taiwan and Turkey. The Company... ม.ค. 55

Boston Scientific Receives CE Mark Approval for New Apex(TM) PTCA Dilatation Catheters

- New Design Offers Greater Flexibility in the Management of Patients With Complex Atherosclerosis Boston Scientific Corporation (NYSE: BSX) announced today that the Apex(TM) Monorail and Over-The-Wire (OTW) PTCA... ต.ค. 50

Stroke, Death, and TIA Rates Significantly Reduced With Closed-Cell Carotid Stents

Data From Multicentre Registry Show Significant Benefit With Closed-Cell Stents in the Treatment of Carotid Artery Stenosis Boston Scientific Corporation (NYSE: BSX) welcomed results from a large independent registry... พ.ค. 50

Data Presented to FDA Panel Show TAXUS(TM) Drug-Eluting Stents as Safe as Bare-Metal Stents and Far More Effective in Reducing Repeat Procedures

Boston Scientific Corporation (NYSE: BSX) yesterday presented data on its long-term randomized clinical trials to a special U.S. Food and Drug... ธ.ค. 49

Study Favours TAXUS(TM) Stent Over Cypher(TM) Stent and Bare-Metal Stents in Diabetic Patients

Lower Re-Intervention Rates for the TAXUS Stent in Diabetic Patients Boston Scientific Corporation (NYSE: BSX) today welcomed a presentation by Joost Daemen, M.D., and Patrick Serruys, M.D., entitled "The... พ.ย. 49

AsiaNet Daily Summary - Press Releases for Wednesday, October 25, 2006

INFORMATION MANAGEMENT... MELBOURNE: Aconex will provide its online information management service to Ocean Park Corporation's HK$5.55 billion (US$715 million) Ocean Park Master Redevelopment Project in Hong Kong. www.aconex.com... ต.ค. 49

Independent Meta-Analysis Confirms Safety and Efficacy of TAXUS(TM) Stent

Results also Show Statistically Significant Late Stent Thrombosis Rate for Cypher(TM) Stent vs. Bare-Metal Stent Boston Scientific Corporation (NYSE: BSX) today announced that an independent meta-analysis of more than 3,500... ต.ค. 49

Boston Scientific Becomes Only Company With Two Drug-Eluting Stent Platforms With European Approval of Everolimus-Eluting PROMUS(TM) Stent System

PROMUS stent to complement Company's market-leading TAXUS(TM) stent systems Boston Scientific Corporation (NYSE: BSX) announced today that the PROMUS(TM)... ต.ค. 49

Safety and Efficacy of Drug-Eluting Stents Reaffirmed in New England Journal of Medicine Articles and Editorial

Boston Scientific Corporation (NYSE: BSX) today welcomed the results of two studies and an editorial published in today's edition of The New England Journal of Medicine (NEJM), all of which... ก.ย. 49

SPIRIT II Results Highlight Strength of Boston Scientific Stent Portfolio

- International Data Suggests Low Revascularization Rates for Both TAXUS(TM) Stent and PROMUS(TM) (XIENCE(TM) V) Stent Boston Scientific Corporation (NYSE: BSX) today welcomed the results of Abbott's SPIRIT II clinical trial,... ก.ย. 49

OLYMPIA Phase I Registry Confirms Safety and Performance of TAXUS(TM) Liberte(TM) Stent System in Complex Patients and Lesions

Initial Six-Month Results Show Positive Outcomes in Diabetic Patients; Safety Events for Diabetic Subset Lower Than Overall Patient Population Boston Scientific Corporation ... ก.ย. 49

TAXUS II Clinical Trial Follow-Up Data Demonstrates Excellent Long-Term Outcomes at Four Years

- Overall Cardiac Death Rate for Combined Bare-Metal Control Group Equivalent to TAXUS Slow- and Moderate-Release Formulations Boston Scientific Corporation (NYSE: BSX) today announced four-year follow-up... ก.ย. 49

AsiaNet Daily Summary - Press Releases for Friday, September 1, 2006

SPORTS WAGERING... ST. JOHNS: SPORTSBETTING.COM, a recognized leader in Internet sports wagering, brings back the $500,000 Gridiron Pick'em a free prediction contest on this year's pro football season. http://www.sportsbetting.com... ก.ย. 49

World's Largest Drug-Eluting Stent Registry Reaches Halfway Point in Enrollment

Results Expected to Continue to Support Safety and Performance of Boston Scientific's Second-Generation Drug-Eluting Stent System Boston Scientific Corporation (NYSE: BSX) announced today that enrollment has exceeded 13... ก.ย. 49

Study of Boston Scientific's Carotid WALLSTENT(TM) Monorail(TM) Design Shows Superior Safety Results in Stroke Prevention

Boston Scientific Corporation (NYSE: BSX) today welcomed the results of a new study, led by Dr. Marc Bosiers of Belgium, demonstrating that the closed cell design of Boston... มิ.ย. 49

TAXUS ATLAS Trial Supports Excellent Deliverability and Proven Outcomes of TAXUS(R) Liberte(TM) Stent System

Boston Scientific's second generation stent compares favorably to market leading TAXUS Express2(TM) stent system, even with more complex lesions Boston Scientific Corporation (NYSE: BSX) today... พ.ค. 49